Joe Ziolkowski, CEO of Relm Insurance delves into the evolving landscape of insurance for emerging and high-risk industries. They specifically addressed the significant insurance gaps for THC beverages and the prevalent underinsurance within the broader cannabis sector. Ziolkowski highlighted Relm Insurance's strategic diversification within the cannabis market, expanding its operations and achieving 50-state Managing General Agent (MGA) status to enhance accessibility and direct engagement with clients.

The discussion also covered critical issues like climate change risks impacting cannabis cultivation, underscoring the necessity of robust data collection and compliance for accurate risk modeling and premium setting. Ziolkowski emphasized that meeting higher compliance standards, such as GMP, can lead to more favorable insurance terms. The conversation further explored the regulatory complexities of insuring new products like THC beverages, where traditional product liability may not suffice, and the nascent psychedelics industry, where Relm aims to facilitate business models by finding viable coverage solutions.

We learn about Relm Insurance's deliberate expansion into the AI insurance sector, a move Ziolkowski explained as a natural progression due to the similarities in underwriting new and emerging risks, including data governance challenges and underdeveloped legislative frameworks. He also noted AI's potential to improve efficiency in cannabis, such as in precision farming.

Ziolkowski concluded by stressing Relm's core vision of "making innovation resilient" and their long-term commitment to supporting forward-looking industries like cannabis, psychedelics, and AI, distinguishing them in the insurance market through their dedication to these sectors.

Rama Mayo, the Founder of Hall of Flowers, discussed the upcoming Hall of Flowers events coming to Santa Rosa, California (site of their very first event) as well as hosting their first New York show and its significance for the cannabis industry. Hall of Flowers, a B2B cannabis trade show, has garnered significant praise, particularly for its California events.

Rama shares his and his team's connection to New York City and provided updates on event preparations, including the number of brands and retailers, and highlighted the strategic location and offerings of the New York event.

We also covered Hall of Flowers' commitment to social equity, their strict vetting process for exhibitors and attendees, and the challenges of regulatory compliance.

Cannabis Tax Attorney James B Mann highlights the ongoing frustration within the cannabis industry due to persistent delays in legalization and reform, particularly concerning the SAFER Banking Act and Section 280E.

James addresses the perceived ineffectiveness of current lobbying efforts and explores various legal challenges to Section 280E, noting instances where companies have successfully disputed its application and received tax refunds.

We underscore the critical need for more impactful strategies, including broader public outreach and the implementation of a simpler tax structure, to drive meaningful change in the cannabis sector.

Blunt Business welcomes Joshua Horn, co-chair of Fox Rothschild's LLP's cannabis law practice. We addressed several key issues impacting the cannabis industry, including the detrimental impact of California's upcoming cannabis tax increase, the challenges posed by the persistent illicit market, and the lack of state enforcement against it.

We also addressed the stalled federal rescheduling of cannabis, attributing it to political factors and potential resistance within the DEA, while briefly touching on Pennsylvania's legalization efforts and frustrations with the lack of clear federal regulation.

We also focused on the lack of progress in rescheduling cannabis at the federal level, despite the Biden administration's recommendation. Political factors and potential internal resistance within the DEA were cited as reasons for the delay. We also noted that the federal government's current tax revenue from the existing 280E structure might act as a disincentive for reform.

Anthony Coniglio, CEO at NewLake Partners returns to discussed a possible shifting to an optimistic outlook on cannabis policy, noting concerns about Rand Paul's efforts to strip hemp language from the agriculture appropriations bill and a proposed DOJ rule classifying cannabis users as "dangerous to society."

We also covered DEA Administrator Terrence Cole's confirmation, his strategic priorities not including cannabis rescheduling, and the potential impact of Schedule 3 reclassification on addressing transnational criminal organizations, with Anthony clarifying that the DEA's priorities align with the National Drug Threat Assessment.

The participants also discussed the rescheduling process and timeline, and the actions taken by states to ban or regulate intoxicating hemp-derived THC products.

Joshua Bauchner, chair of the Cannabis, Hemp and Psychedelics Practice Group of Mandelbaum Barrett, P.C., discusses the intricacies of medical cannabis use and its legal implications. While some states provide protections for medical cannabis users, federal law does not, limiting the scope of the Americans with Disabilities Act (ADA).

The inconsistency between state and federal laws creates additional challenges for both employers and employees. The discussion further explored the potential impacts of DEA rescheduling or descheduling cannabis, including possible changes to ADA protections and tax implications for cannabis businesses. Ultimately, prioritizing the passage of the Safe Banking Act and amending Section 280E of the IRS code were identified as more effective solutions for addressing industry challenges.

Blunt Business welcomes back Nishant Reddy to talk about the launch of Phases and Smack Studios as extensions of A Golden State, aiming for approachable pricing while maintaining quality across vaporizers, edibles, and infused pre-rolls.

Nishant highlighted the challenges in California's cannabis market due to taxation and regulation, but noted the success of their brands due to a focus on quality and the unique consumer experience offered at their flagship retail store.

The conversation covered brand strategies, market trends, and frustration with California's business environment, while also introducing the new brand Smack Studios with its unique genetics and artist collaborations.

Blunt Business welcomes back with Sara Gullickson, founder and CEO of CB Advisors, regarding the current landscape of the cannabis industry. Key topics included the inconsistent regulations across different states, particularly in the Southeast, and the significant challenges faced during Minnesota's cannabis program rollout. Gullickson emphasized the detrimental effects of unregulated hemp-derived cannabinoid products on legitimate cannabis businesses and the critical need for better industry oversight and sufficient capital for businesses to thrive.

The conversation highlighted the complexities of federal intervention versus industry self-regulation, drawing parallels to existing regulatory frameworks. A major point of concern was Minnesota's flawed social equity lottery system, which has created an uneven playing field for applicants and led to market saturation due to unlimited licensing. The discussion also covered the substantial capital requirements for success in the evolving cannabis market, which has shifted from a grassroots movement to one dominated by larger corporations.

The meeting concluded with a look at the future of the cannabis industry, including the Treasury Department's proposal for financial data collection to combat money laundering. Gullickson underscored the importance of the industry establishing a clear path forward, advocating for either complete federal legalization or a merit-based, limited licensing system. There was also an optimistic outlook on the potential passage of some form of the Safer Banking Act under the current presidential administration.